Style | Citing Format |
---|---|
MLA | Soleimani M, et al.. "Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration." Social Health and Behavior, vol. 1, no. 2, 2018, pp. 48-53. |
APA | Soleimani M, Sharif S, Yaghoobzadeh A, Allen K (2018). Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration. Social Health and Behavior, 1(2), 48-53. |
Chicago | Soleimani M, Sharif S, Yaghoobzadeh A, Allen K. "Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration." Social Health and Behavior 1, no. 2 (2018): 48-53. |
Harvard | Soleimani M et al. (2018) 'Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration', Social Health and Behavior, 1(2), pp. 48-53. |
Vancouver | Soleimani M, Sharif S, Yaghoobzadeh A, Allen K. Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration. Social Health and Behavior. 2018;1(2):48-53. |
BibTex | @article{ author = {Soleimani M and Sharif S and Yaghoobzadeh A and Allen K}, title = {Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration}, journal = {Social Health and Behavior}, volume = {1}, number = {2}, pages = {48-53}, year = {2018} } |
RIS | TY - JOUR AU - Soleimani M AU - Sharif S AU - Yaghoobzadeh A AU - Allen K TI - Fear of Negative Evaluation and Social Well-Being in Patients With Multiple Sclerosis: The Moderating Role of Disease Duration JO - Social Health and Behavior VL - 1 IS - 2 SP - 48 EP - 53 PY - 2018 ER - |